Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine–N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leu...

por Omran, Mervat M., Abdelfattah, Raafat, Moussa, Heba S., Alieldin, Nelly, Shouman, Samia A.
Publicado 2020

Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients

por Hamza, Marwa S, Shouman, Samia A, Abdelfattah, Raafat, Moussa, Heba S, Omran, Mervat M
Publicado 2022

PB2419: THE OUTCOME OF VIRAL HEPATITIS-C INFECTION ON HEMATOLOGICAL MALIGNANCIES AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION IN EGYPT

por Elashwah, Salma, Elbaiomy, MA, Samra, Mohamed, El-Ashwah, Shaimaa, Abdelfattah, Raafat, Fathy, Gamal, Shamaa, Sameh
Publicado 2023

Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters

por Omran, Mervat M., Shouman, Samia A., Abdelfattah, Raafat, Moussa, Heba S., Thabet, Nadia A., Hamza, Marwa S.
Publicado 2022

Cancer Stem Cells as a Prognostic Biomarker and Therapeutic Target Using Curcumin/ Piperine Extract for Multiple Myeloma

por Mekkawy, Sara A., Abdalla, Mohga S., Omran, Mohamed M., Hassan, Naglaa M., Abdelfattah, Raafat, Abdel-Salam, Ibrahim M.
Publicado 2022

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders

por Mahmoud, Hossam K., Elhaddad, Alaa M., Fahmy, Omar A., Samra, Mohamed A., Abdelfattah, Raafat M., El-Nahass, Yasser H., Fathy, Gamal M., Abdelhady, Mohamed S.
Publicado 2015

Evaluation of prognostic variables in chronic lymphocytic leukemia and association with disease stage

por Attia, Hanaa R.M., Ibrahim, Mona Hamed, El-Aziz, Shereen H. Abd, Abdelrahman, Amany H., Sobeih, Mohamed Emam, Hagag, Heba A.A., Yassa, Marianne E., Osman, Randa A., Rawi, Rasha, El-Dayem, Omnia Y. Abd, Elsharkawi, Nahla, Abdelfattah, Raafat, Hassan, Naglaa M.
Publicado 2021